These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 14567255

  • 61. [Antibacterial activities of isepamicin against fresh clinical isolates of gram-negative bacilli].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S, Tanaka S, Nakane Y, Fukamoto T.
    Jpn J Antibiot; 1994 Aug; 47(8):1053-64. PubMed ID: 7933534
    [Abstract] [Full Text] [Related]

  • 62. [Susceptibility of clinical isolates to aztreonam].
    Nagasawa Z, Nishimura T, Nagumo F, Ueda H, Tadano J, Katoh O, Yamada H.
    Jpn J Antibiot; 1989 Jun; 42(6):1257-70. PubMed ID: 2507799
    [Abstract] [Full Text] [Related]

  • 63. In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.
    Chin NX, Gu JW, Fang W, Neu HC.
    Antimicrob Agents Chemother; 1991 Feb; 35(2):259-66. PubMed ID: 2024959
    [Abstract] [Full Text] [Related]

  • 64. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H, Takeda H, Kawai S, Watanabe S, Okazaki M, Shimada K, Nakano K, Yokouchi H, Mori T, Igari J, Oguri T, Yamamoto M, Kudo K, Kobayashi N, Tanaka T, Yoshimura K, Kawabata M, Nakamori Y, Sumitomo M, Inoue H, Nakadate T, Suwabe A, Ashino Y, Aoki N, Honma Y, Suzuki Y, Karasawa Y, Oka M, Kobashi Y, Kohno S, Hirakata Y, Kondou A, Matsuda J, Nakano M, Oikawa S.
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [Abstract] [Full Text] [Related]

  • 65. [Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
    Abe T, Fukuoka T, Sato Y, Ito K, Sei M.
    Jpn J Antibiot; 2002 Dec; 55(6):827-43. PubMed ID: 12621736
    [Abstract] [Full Text] [Related]

  • 66. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW, Xu YC, Chen MJ, Hu YJ, Ni YX, Sun JY, Yu YS, Kong HS, He L, Wu WY, Ye HF, Yang YM, Zhu LN, Guo SH, Ji P, Zhu ZH, Ren JK, Zhang LX, Sun ZY, Zhu XH, Tong MQ, Zhao WS, Mei YN, Liu Y, Zhang ZJ, Duan Q, Li D, Liu PP, Wang J, Han LX, Wang H, Xie XL.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2753-8. PubMed ID: 18167265
    [Abstract] [Full Text] [Related]

  • 67. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
    Johnson DM, Jones RN.
    Eur J Clin Microbiol Infect Dis; 1992 Feb 23; 11(2):181-8. PubMed ID: 1396735
    [Abstract] [Full Text] [Related]

  • 68. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T, Takeda Y, Kotera K, Nishimura T, Takashima T, Hiromatsu K, Tabuki K, Fujimoto S, Kamiki T, Yoshizaki E, Yabuuchi E, Shimizu Y, Matsunaga K, Yamanaka K, Furuta I, Iimori M, Kodama J, Tanaka M, Maejima K, Nukina M, Takashima E, Takahashi M, Harikane O, Masutani T.
    Jpn J Antibiot; 1983 Feb 23; 36(2):260-76. PubMed ID: 6304368
    [Abstract] [Full Text] [Related]

  • 69. [Antibacterial activity of aztreonam against clinical isolates].
    Igari J.
    Jpn J Antibiot; 1994 May 23; 47(5):502-20. PubMed ID: 8051793
    [Abstract] [Full Text] [Related]

  • 70. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002].
    Abe T, Sato Y, Sei M.
    Jpn J Antibiot; 2003 Dec 23; 56(6):574-83. PubMed ID: 15007873
    [Abstract] [Full Text] [Related]

  • 71. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). I. Susceptibility distribution].
    Kosakai N, Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1989 Oct 23; 42(10):2141-73. PubMed ID: 2691714
    [Abstract] [Full Text] [Related]

  • 72. In Vitro Activity of MRX-8 and Comparators Against Clinical Isolated Gram-Negative Bacilli in China.
    Wu S, Yin D, Zhi P, Guo Y, Yang Y, Zhu D, Hu F.
    Front Cell Infect Microbiol; 2022 Oct 23; 12():829592. PubMed ID: 35646734
    [Abstract] [Full Text] [Related]

  • 73. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY, Chang SC, Hsueh PR, Feng NH, Wang JT.
    J Microbiol Immunol Infect; 2007 Dec 23; 40(6):481-6. PubMed ID: 18087627
    [Abstract] [Full Text] [Related]

  • 74. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan 23; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 75. [In-vitro activity of panipenem against clinical isolates in 2006].
    Yoshida S, Koga T, Kakuta M, Kobayashi I, Matsuzaki K, Urabe E, Omika K, Hasegawa M, Sato Y.
    Jpn J Antibiot; 2008 Feb 23; 61(1):1-17. PubMed ID: 18536215
    [Abstract] [Full Text] [Related]

  • 76. [Antimicrobial activities of cefepime against clinically isolated strains].
    Suzuki Y, Koguchi M, Tanaka S, Fukayama S, Ishihara R, Deguchi K, Oda S, Nakane Y, Fukumoto T.
    Jpn J Antibiot; 1995 Dec 23; 48(12):1906-19. PubMed ID: 8587165
    [Abstract] [Full Text] [Related]

  • 77. [In vitro antibacterial activity of cefpirome: a new cephalosporin; results of a multicenter study].
    Soussy CJ, Chanal M, Derlot E, Goldstein F, Duval J.
    Pathol Biol (Paris); 1994 Oct 23; 42(8):754-60. PubMed ID: 7724247
    [Abstract] [Full Text] [Related]

  • 78. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM, Aranza MK, Shah D, Sahm DF.
    J Antimicrob Chemother; 2008 Mar 23; 61(3):595-602. PubMed ID: 18218646
    [Abstract] [Full Text] [Related]

  • 79. [Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
    Suzuki Y, Nishinari C, Endo H, Tamura C, Jinbo K.
    Jpn J Antibiot; 2001 Sep 23; 54(9):473-90. PubMed ID: 11729712
    [Abstract] [Full Text] [Related]

  • 80. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H, Ito C, Yoshida T, Watanabe K, Mori T, Ohno I, Okada S, Igari J, Arakawa M, Igarashi K, Oguri T, Okada M, Ozaki K, Terai T, Aoki N, Inoue H, Nakadate T, Kitamura N, Sekine O, Suzuki Y, Ando M, Suga M, Sato K, Nakata K, Kusano N.
    Jpn J Antibiot; 1999 May 23; 52(5):353-97. PubMed ID: 10480048
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.